Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized crossover trial of TIROSINT versus EUTIROX intestinal effects in pediatric primary acquired hypothyroidism
2015-001248-12Phase 4Terminated
- Sponsor
- Meyer Organics
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levothyroxine and levothyroxine sodium in primary hypothyroidism (PH) and acquired hypothyroidism (AH) (2 arms), sponsored by Meyer Organics. Primary endpoint: Difference in gut inflammation and absorption parameters between formulations. Started Nov 2020; status: terminated.
02
Drugs
levothyroxinelevothyroxine sodium
03
Conditions
primary hypothyroidism (PH)acquired hypothyroidism (AH)
Beyond the preview
Go deeper on 2015-001248-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001248-12.